U.S. Renal Care, Inc. (“USRC”), a leading provider of dialysis services for patients suffering from chronic kidney failure, announced a collaboration with Fresenius Medical Care North America, DaVita Inc., and other organizations in response to the developing public health crisis caused by the novel coronavirus (COVID-19). This collaboration will support dialysis patients with COVID-19 in their continued treatment by creating a safety network of dialysis clinics that focus on patients affected by the novel coronavirus.
The organizations are working closely to ensure the continuity of care for their patients through the use of specially designated safety clinics that can be accessed by other dialysis providers in the event that a patient tests positive for COVID-19. These safety clinics will be equipped and managed with infection control designed for patients suspected of being impacted by COVID-19.
The initiative is intended to relieve the burden on hospitals while ensuring the adequate staffing of nurses, social workers, dieticians, care technicians, and other staff to treat patients that have contracted COVID-19 without exposing those who are healthy.
“U.S. Renal Care is proud to be working closely with other national providers to create a safety net ensuring that all 500,000 kidney disease patients will have access to safe, effective treatment every day”, said Mary Dittrich, M.D., Chief Medical Officer and interim CEO of U.S. Renal Care.
More information regarding this effort can be found from the Kidney Community Emergency Response (KCER) Program at kcercoalition.com.